PRESS RELEASES
SAN FRANCISCO, November 20, 2008 CA-InCode-Announces
November 20, 2008, SAN FRANCISCO - InCode BioPharmaceutics Appoints New President and CEO
SAN FRANCISCO, July 23, 2008 CA-InCode-Announces
July 23 2008, SAN FRANCISCO - InCode BioPharmaceutics, Inc., an emerging biopharmaceutical company, today announced preclinical test results demonstrating the utility of their lead drug candidate rC3-1 for the treatment of the rare chronic blood disorder paroxysmal nocturnal hemoglobinuria (PNH)